Showing 241-250 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Enhancing Tidepool Loop for Unannounced Meals Tidepool Brandon Arbiter Improving Lives 01-June-2026 to 31-May-2029 $2.175.732,12
Development of Low Cost, High Precision Nano Pumps for Insulin Delivery Torramics Inc. Sergey Gimelshein Improving Lives 01-March-2023 to 30-April-2027 $1.493.212,43
Achieving persistent presentation of self-antigens to reestablish tolerance and prevent autoimmune diabetes Trustees of Columbia University in the City of New York Camillo Bechi Genzano Cures 01-March-2025 to 29-February-2028 $253.647,64
Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts Trustees of Columbia University in the City of New York Megan Sykes Cures 01-June-2024 to 30-November-2026 $791.063,66
Preclinical optimization of Treg therapy to reverse autoimmunity in T1D patient-derived immune systems Trustees of Columbia University in the City of New York Megan Sykes Cures 01-August-2026 to 31-July-2029 $1.189.893,00
Determining the role of SSTR2 on PRL-2903-mediated glucagon secretion Trustees of Columbia University in the City of New York Xiaojuan Chen Improving Lives 01-April-2026 to 31-March-2027 $199.999,39
Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes Trustees of Indiana University Amelia Linnemann Cures 01-October-2023 to 31-December-2026 $560.000,00
β Cell Mitochondrial Health as a Driver and Indicator of Immune Activation in Type 1 Diabetes Trustees of Indiana University Carmella Evans-Molina Cures 01-March-2026 to 28-February-2029 $748.179,00
Defining the role of islet-derived extracellular vesicle PD-L1 cargo in type-1 diabetes Trustees of Indiana University Chaitra Rao Cures 01-March-2024 to 30-April-2027 $215.972,69
Optimizing Approaches to Type 1 Diabetes Prediction and Intervention in the Adult Autoantibody Positive Population Trustees of Indiana University Emily Sims Cures 01-February-2026 to 31-January-2029 $691.694,00